A. Włodarczyk

发表

Phenotypical Flexibility of the EGFRvIII-Positive Glioblastoma Cell Line and the Multidirectional Influence of TGFβ and EGF on These Cells—EGFRvIII Appears as a Weak Oncogene

P. Rieske, E. Stoczyńska-Fidelus, Cezary Treda, 2022, International journal of molecular sciences.

Multiomic analysis on human cell model of wolfram syndrome reveals changes in mitochondrial morphology and function

M. Borowiec, J. Mancias, M. Wieckowski, 2021, Cell Communication and Signaling.

Proteomic and Transcriptomic Landscapes of Alström and Bardet–Biedl Syndromes

M. Borowiec, J. Mancias, W. Młynarski, 2022, Genes.

A way to understand idiopathic senescence and apoptosis in primary glioblastoma cells – possible approaches to circumvent these phenomena

Róża Pawłowska, P. Rieske, E. Stoczyńska-Fidelus, 2019, BMC Cancer.

EGFRvIII: An Oncogene with Ambiguous Role

P. Rieske, E. Stoczyńska-Fidelus, K. Janik, 2019, Journal of oncology.

EGFR: An Oncogene with Ambiguous Role

P. Rieske, E. Stoczyńska-Fidelus, K. Janik, 2019 .

Gaps and Doubts in Search to Recognize Glioblastoma Cellular Origin and Tumor Initiating Cells

P. Rieske, E. Stoczyńska-Fidelus, D. Grot, 2020, Journal of oncology.

Increased EGFRvIII Epitope Accessibility after Tyrosine Kinase Inhibitor Treatment of Glioblastoma Cells Creates More Opportunities for Immunotherapy

P. Rieske, E. Stoczyńska-Fidelus, Cezary Treda, 2023, International journal of molecular sciences.

A way to understand idiopathic senescence and apoptosis in primary glioblastoma cells – possible approaches to circumvent these phenomena

Róża Pawłowska, P. Rieske, E. Stoczyńska-Fidelus, 2019, BMC Cancer.

The hope, hype and obstacles surrounding cell therapy

A. Włodarczyk, Cezary Tręda, Piotr Rieske, 2024, Journal of cellular and molecular medicine.